Fig. 6From: Clinical significance of CDH13 promoter methylation as a biomarker for bladder cancer: a meta-analysisForest plot of the correlation between CDH13 methylation and tumor number form a fixed-effects model, including 5 studies with 319 bladder cancer patients with multiple tumors and 281 bladder cancer patients with single tumors, OR = 1.45, 95 % CI = 1.03–2.04, P = 0.032Back to article page